RIPK3 and Other metabolic disease: Given the significant and distinct roles of the RIP1-RIP3-MLKL axis in metabolic diseases of various etiologies, researchers have investigated the potential of circulating concentrations of RIP1, RIP3, and MLKL as potential biomarkers in humans.